Final Report: A pilot study to assess training and communication materials on progestogen-only injectable use and risk of HIV acquisition in Tanzania

In February 2018, Marie Stopes Tanzania (MST) undertook a study to understand provider and client comprehension of the WHO’s new guidance on progestogen-only injectable contraception use among women at high risk for HIV, and how the new recommendations affect clients’ decision-making on contraception. Semi-structured interviews with clients suggested that while most understood there was a link between DMPA use and risk of HIV acquisition, they did not always accurately characterise the nature or extent of the risk.